INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2021

Apr 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2021-04-16

Reporting Person: BENITO SIMON X (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-16	Common Stock	M	2000	$3.56	Acquired	53650	Direct
2021-04-16	Common Stock	S	2000	$8.75	Disposed	51650	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-16	Common Stock Options	$3.56	M	2000	Disposed	2021-05-13	Common Stock (2000.0)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2: Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.